WO2011094504A4 - Antimicrobial sinus irrigation compositions, methods, and devices - Google Patents

Antimicrobial sinus irrigation compositions, methods, and devices Download PDF

Info

Publication number
WO2011094504A4
WO2011094504A4 PCT/US2011/022874 US2011022874W WO2011094504A4 WO 2011094504 A4 WO2011094504 A4 WO 2011094504A4 US 2011022874 W US2011022874 W US 2011022874W WO 2011094504 A4 WO2011094504 A4 WO 2011094504A4
Authority
WO
WIPO (PCT)
Prior art keywords
agent
antimicrobial
nasal irrigation
irrigation fluid
group
Prior art date
Application number
PCT/US2011/022874
Other languages
French (fr)
Other versions
WO2011094504A3 (en
WO2011094504A2 (en
Inventor
Aron M. Shapiro
Peter N. Friedensohn
Leo P. Menard
Stephanie K. Lynch
George E. Minno
Jacquelyn M. Nice
Original Assignee
Ora, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ora, Inc. filed Critical Ora, Inc.
Publication of WO2011094504A2 publication Critical patent/WO2011094504A2/en
Publication of WO2011094504A3 publication Critical patent/WO2011094504A3/en
Publication of WO2011094504A4 publication Critical patent/WO2011094504A4/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00Medical syringes, e.g. enemata; Irrigators
    • A61M3/02Enemata; Irrigators
    • A61M3/0279Cannula; Nozzles; Tips; their connection means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00Medical syringes, e.g. enemata; Irrigators
    • A61M3/02Enemata; Irrigators
    • A61M3/0233Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs
    • A61M3/0245Containers therefor, e.g. with heating means or with storage means for cannula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00Medical syringes, e.g. enemata; Irrigators
    • A61M3/02Enemata; Irrigators
    • A61M3/0233Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs
    • A61M3/0254Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped
    • A61M3/0262Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped manually, e.g. by squeezing a bulb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/20Pathogenic agents
    • A61M2202/203Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/06Head
    • A61M2210/0681Sinus (maxillaris)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This application discloses topical sinus irrigation formulations, uses thereof, and delivery devices thereof.

Claims

AMENDED CLAIMS received by the International Bureau on 23 December 2011 (23.12.2011 )
1. A single-use nasal irrigation delivery device comprising;
a single-use reservoir and an irrigator tip, wherein the single-use reservoir is configured for controlled collapsing to dispense nasal irrigation fluid from the reservoir through a reservoir outlet at the irrigator tip, wherein the irrigator tip is configured to create a seal to the nostril in order to direct a stream of antimicrobial fluid into the sinuses.
2. The single-use nasal irrigation delivery device of claim 1 , wherein the reservoir has a volume capacity of from about 1 ml to about 500 ml.
3. The single-use nasal irrigation delivery device of claim 1 , wherein the irrigator tip has an extension so that the intranasal release of liquid occurs more proximal to the sinuses than with traditional sinus rinse bottles.
4. The single-use nasal irrigation delivery device of claim 1 , wherein the reservoir is shaped like a bellows to allow for controlled collapsing and for the expulsion of the total liquid volume contained in the device without the need for a Straw.
5. The single-use nasal irrigation delivery device of claim 1 , wherein the device is
manufactured so that its liquid contents are sterile.
6. The single-use nasal irrigation delivery device of claim 1 , wherein the device contains a substance comprising one or more pharmaceutical substances selected from the group consisting of an antihistamine agent, a decongestant (vasoconstrictor), an anti-allergy agent, an anti-inflammatory agent (e.g., non-steroidal anti-inflammatory (NSAID) or
corticosteroid), or any combination or mixture thereof,
7. The single-use nasal irrigation delivery device of any one of claims 1 to 5 or any combination of claims 1 to 5, wherein the reservoir contains an antimicrobial nasal irrigation fluid useful for treatment of sinusitis, wherein the antimicrobial nasal irrigation fluid comprises an antimicrobial agent in a therapeutically effective amount, a buffered isotonic, hypertonic, or hypertonic solution having a pH between about 4 and 9, and one or more tastemasking agents selected from the group consisting of sweeteners, a flavoring agents and fragrances.
8. An antimicrobial nasal irrigation fluid useful for treatment of sinusitis, comprising:
an antimicrobial agent in a therapeutically effective amount, a buffered isotonic, hypotonic, or hypertonic solution having a pH between about 4 and 9, and one or more tastemasking agents selected from the group consisting of sweeteners, flavoring agents and fragrances.
9. The antimicrobial nasal irrigation fluid of claim 8, wherein the antimicrobial agent is selected from the group consisting of cephalosporins, penicillins, penicillins, beta lactamase inhibitors, carbepenems, monobactams, macrolides, lincosamines, lipopeptide,
glycopeptides, lipoglycopeptides, carbapenem, rifampin, oxazolidonones, tetracyclines, aminoglycosides, streptogramins, and sulfonamides and combinations thereof.
10. The antimicrobial nasal irrigation fluid of claim 8, wherein the antimicrobial agent is a
quinolone, fluoroquinolone, heteroaryl isothiazolone, or a isothiazoloquinolone,
1 1. The antimicrobial nasal irrigation fluid of claim 8, wherein the antimicrobial agent is
levofloxacin.
12. The antimicrobial nasal irrigation fluid of claim 8, wherein the antimicrobial agent has a concentration from about 0.1% to about 30%.
13. The antimicrobial nasal irrigation fluid of any one of claims 7 to 12, further comprising one or more pharmaceutical substances selected from the group consisting of an antihistamine agent, a decongestant (vasoconstrictor), an anti-allergy agent, an anti-inflammatory agent (e.g., non-steroidal anti-inflammatory (NSAID) οτ corticosteroid), or any combination or mixture thereof.
14. A method of treating a patient with sinusitis comprising intranasally administering to said patient a therapeutically effective amount of the antimicrobial nasal irrigation fluid of any one of claims 7 to 13 using the device of any one of claims 1 to 5 or any combinations of claims 1 to 5.
15. The method of claim 14, wherein the sinusitis is the result of microbial infection.
16. The method of claim 14, wherein the sinusitis is the result of bacterial infection.
17. A nasal irrigation fluid useful for treatment of a medical condition of the sinonasal tract, comprising: one or more pharmaceutical substances selected from the group consisting of an antimicrobial, an antihistamine agent, a decongestant (vasoconstrictor), an anti-allergy agent, a fibrotic agent, an anti-inflammatory agent {e.g., non-steroidal anti-inflammatory (NSAID) or corticosteroid), a pro-coagulant agent, an anti-fibrotic agent, an anti -metabolite agent, an anti-cancer agent, a surfactant or any combination or mixture thereof in a therapeutically effective amount, a buffered isotonic, hypotonic, or hypertonic solution having a pH between about 4 and 9, and one or more tastemasking agents selected from the group consisting of sweeteners, flavoring agents and fragrances.
18. A method of treating a patient with a medical condition of the sinonasal tract comprising intranasally administering to said patient a therapeutically effective amount of the nasal irrigation fluid of claim 17.
19. A method of treating a patient with a medical condition of the sinonasal tract comprising intranasally administering to said patient a therapeutically effective amount of the nasal irrigation fluid of claim 18 using the device of any one of claims 1 to 5 or any combination of claims 1 to 5.
20. The single-use nasal irrigation delivery device of any one of claims 1 to 5 or any combination of claims 1 to 5, wherein the reservoir contains a nasal irrigation fluid useful for treatment of a medical condition of the sinonasal tract, comprising: one or more pharmaceutical substances selected from the group consisting of an antimicrobial, an antihistamine agent, a decongestant (vasoconstrictor), an anti-allergy agent, a fibrotic agent, an anti-inflammatory agent (e.g., non-steroidal anti-inflammatory (NSAID) or corticosteroid), a pro-coagulant agent, an anti-fibrotic agent, an anti-metabolite agent, an anti-cancer agent, a surfactant or any combination or mixture thereof in a therapeutically effective amount, a buffered isotonic, hypotonic, or hypertonic solution having a pH between about 4 and 9, and one or more tastemasking agents selected from the group consisting of sweeteners, flavoring agents and fragrances.
PCT/US2011/022874 2010-01-28 2011-01-28 Antimicrobial sinus irrigation compositions, methods, and devices WO2011094504A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29905110P 2010-01-28 2010-01-28
US61/299,051 2010-01-28

Publications (3)

Publication Number Publication Date
WO2011094504A2 WO2011094504A2 (en) 2011-08-04
WO2011094504A3 WO2011094504A3 (en) 2011-12-29
WO2011094504A4 true WO2011094504A4 (en) 2012-02-16

Family

ID=44320139

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/022874 WO2011094504A2 (en) 2010-01-28 2011-01-28 Antimicrobial sinus irrigation compositions, methods, and devices

Country Status (1)

Country Link
WO (1) WO2011094504A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017313532A1 (en) * 2016-08-15 2019-03-07 Rhinoclear Nasal Care Solutions Inc. Nasal irrigation apparatus and kit
US20180071281A1 (en) * 2016-08-19 2018-03-15 Gerbe Labs Inc. Treating chronic rhinosinusitis
US10420776B2 (en) * 2016-10-13 2019-09-24 RhinoNase, Inc. Antibiotic compositions for nasal irrigation and methods
US20210330584A1 (en) * 2020-04-22 2021-10-28 Topical Sinus Therapeutics, Inc. Topical preparations of drug delivery for nasal and sinus irrigation
MX2023007926A (en) * 2020-12-31 2023-10-12 Ntby Moss Llc Formulations of a prophylactic nasal spray and methods of use and manufacture thereof.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2367756B (en) * 2000-10-12 2003-01-08 Bespak Plc Dispensing apparatus
WO2002041837A2 (en) * 2000-11-22 2002-05-30 Rxkinetix, Inc. Treatment of mucositis
GB0215904D0 (en) * 2002-07-09 2002-08-21 Team Holdings Uk Ltd Drug delivery system and method
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof

Also Published As

Publication number Publication date
WO2011094504A3 (en) 2011-12-29
WO2011094504A2 (en) 2011-08-04

Similar Documents

Publication Publication Date Title
US11723859B2 (en) Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity
WO2011094504A4 (en) Antimicrobial sinus irrigation compositions, methods, and devices
WO2003020219B1 (en) Aerosolized decongestants for the treatment of sinusitis
US20160166505A1 (en) Methods And Compositions For Treatment Of Respiratory Tract Infections
JP2013524960A (en) Method for operating aerosol delivery device and aerosol delivery device
MX2008010351A (en) Pharmaceutical formulations.
JP2011520894A5 (en)
WO2007112274A3 (en) Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin
RS54438B1 (en) Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
US20220160677A1 (en) Tumescent infiltration drug delivery of cannabinoids
US20160279057A1 (en) Azelastine Formulations For Intranasal Nebulization And Irrigation
JP2022525762A (en) Materials and methods to enhance the treatment and prevention of biofilm formation
KR20150012305A (en) catheter for photodynamic therapy
US20160022595A1 (en) Bioadhesive and biodegradable and formulations that provide sustained release of antimicrobials, bacteriophages and anti-inflammatory medications for inactivation of biofilms and the treatment of rhinosinusitis and other infections
US20180071281A1 (en) Treating chronic rhinosinusitis
US10493218B2 (en) Device for delivery of an aerosol substance
US20160317546A1 (en) Method for treating otic infections after tympanostomy tube placement
WO2021216915A1 (en) Topical preparations of drug delivery for nasal and sinus irrigation
JP2019516797A5 (en)
WO2020160328A1 (en) Tumescent infiltration drug delivery of cannabinoids
JP2016527322A5 (en)
CN205460414U (en) Soft pipe of spraying in air flue
Kumar Topical Management of Chronic Rhinosinusitis
US20240148776A1 (en) Tumescent solution with b vitamins
CN203107976U (en) Double-end treatment tube used in medical oncology

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11737707

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11737707

Country of ref document: EP

Kind code of ref document: A2